Pharmafile Logo
Pharmafocus logo
Advanced Search

Cally Clarkson joins HealthEd

February 25, 2011
Medical Communications Cally Clarkson, HealthEd, appointment, medical communications

Cheshire, UK-based medical education agency HealthEd has appointed Cally Clarkson as client services director. She has 10 years of healthcare …

Appointment
MedImmune

Retaining pharma top talent

February 25, 2011
Business Services MedImmune, careers, recruitment, talent retention

Strategies to co-ordinate talent retention differ between companies, and they may not always be as forward-focused as they could – …

Feature

Glioblastoma vaccine enters phase II

February 24, 2011
Research and Development Cancer, GBM, ImmunoCellular Therapeutics, oncology

The first patient has been enrolled in a phase II trial of ICT-107, a cancer vaccine candidate for the treatment …

News
Blog footer

Digital Pharma: Sanofi shifts video focus to YouTube

February 24, 2011
Medical Communications Digital Pharma blog, Sanofi-Aventis, online pharma video, youtube

Sanofi-Aventis has scaled back its online video ambitions and moved its web TV channel to YouTube. The move sees the …

News

Working Life: BMS UK’s market access director Patrick Hopkinson

February 24, 2011
Business Services, Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, Patrick Hopkinson, Working Life, recruitment

Patrick Hopkinson, director of market access and external affairs at Bristol-Myers Squibb UK, talks to Pharmafocus about how he got …

News
astrallas_minesh_ghelani

Minesh Ghelani joins Astralis Group

February 24, 2011
Business Services Astralis Group, Mishesh Ghelani, appointment, business services

Recruitment consultancy Astralis has appointed Minesh Ghelani as a senior consultant to its Life Sciences Practice.After obtaining his degree in …

Appointment
Abbott's Humira (adalimumab)

Abbott wins $1.7bn Humira case

February 24, 2011
Sales and Marketing Abbott, Abbott Laboratories, Centocor, Johnson and Johnson, Remicade, Simponi, TNF, golimumab, infliximab, rheumatoid arthritis

Abbott has been saved from paying Johnson & Johnson $1.7 billion after a US appeals court quashed a patent dispute …

News

50,000 NHS jobs to be cut

February 24, 2011
False Economy, GPs, NHS, NHS reforms, TUC, nurses

NHS trusts are preparing to make a major series of job cuts as the health service wrestles with the need …

News

Red Door boosts management team

February 24, 2011
Medical Communications Laura Clark, Liz Adams, Red Door Communications, appointment, medical communications

Red Door Communications has appointed its first `home grown’ consultant to its management team. Laura Clark has been made an …

Appointment
Roche building

Roche pulls out of vaccine alliance with Transgene

February 23, 2011
Research and Development HPV, HPV vaccine, Roche, TG4001, Transgene, cervical cancer, cervical lesions, human papilloma virus, vaccines

Roche has terminated its license agreement with Transgene for its HPV therapeutic vaccine TG4001. The vaccine is currently being tested …

News

Online international research register launched

February 23, 2011
Research and Development CRD, Centre for Reviews and Dissemination, Department of Health, NIHR, National Institute for Health Research, Prospero, clinical research, health research register

The UK government has backed the creation of a free, international online register to improve the transparency of health research. …

News
Lung cancer cells

No magic bullet, but a growing arsenal against lung cancer

February 23, 2011
Research and Development ASA404, Cancer, Iressa, NSCLC, Tarceva, afatinib, crizotinib, figitumumab, lung cancer, non small cell lung cancer, non-small cell lung cancer

A man in his 70s is waiting for his appointment with the oncologist after being referred there by his family …

Feature

J&J hepatitis C drug begins phase III trials

February 23, 2011
Research and Development J&J, JJ, Johnson and Johnson, TMC435, Tibotec, hepatitis, hepatitis C

Johnson & Johnson has begun late stage trials of hepatitis C drug TMC435 as a first line treatment for the …

News
Roche's Avastin (bevacizumab)

NICE yes for Votrient, no to Avastin

February 23, 2011
Sales and Marketing Cancer, GSK, GlaxoSmithKline, Kidney cancer, NICE, Roche, avastin, bevacizumab, breast cancer

NICE has recommended GlaxoSmithKline’s kidney cancer drug Votrient on the same day it gave a final negative decision to Roche’s …

News

Commissioning Board to spearhead NHS reforms

February 23, 2011
GP consortia, Health and Social Care Bill, NHS, NHS Commissioning Board, NHS reforms, PCT clusters, PCTs, SHAs, Sir David Nicholson, pathfinder consortia

NHS chief executive Sir David Nicholson says the new NHS Commissioning Board will be the driving force behind the health …

News
ge_healthcare_kieran_murphy

Kieran Murphy to head up life sciences for GE Healthcare

February 23, 2011
Research and Development, Sales and Marketing GE Healthcare, Kieran Murphy, appointment, research and development, sales and marketing

GE Healthcare has promoted Kieran Murphy to succeed its current Life Sciences president and chief executive Peter Ehrenheim. Kieran, who …

Appointment

Contract research news in brief

February 23, 2011
Research and Development Bioanalytical Systems, Evotec, Iris Pharma, Kancera, Kinaxo Biotechnologies, NSF International, Pharmalytica Services, iNovacia

Acquisitions by Evotec, Kancera and NSF International head our latest CRO news round-up, along with updates from BASi and Iris …

News

Sanofi partners on dengue vaccine awareness

February 22, 2011
Medical Communications, Research and Development Dengue Vaccine Institute, Dengue fever, International Vaccine Institute, Sanofi Pasteur, Sanofi-Aventis, disease awareness, vaccines

Sanofi-Aventis has teamed up with the International Vaccine Institute to raise awareness about dengue fever and its vaccine for the …

News

Scottish biotech ProStrakan sold for £292m

February 22, 2011
Research and Development KHK, Kyowa Hakko Kirin, ProStrakan, Scottish biotech, biotech

Scottish biotech ProStrakan is to be bought by Japanese manufacturer Kyowa Hakko Kirin for £292 million. The companies agreed the …

News

Pharma must rethink manufacturing, says PwC

February 22, 2011
Manufacturing and Production pharma manufacturing, pricewaterhousecoopers, pwC

The pharmaceutical industry needs to undertake a radical overhaul in its approach to manufacturing which at present is “inefficient, under-utilised …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026